These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The importance of the state medical journal to the pharmaceutical industry. Stetler CJ J Med Assoc Ga; 1968 Feb; 57(2):73-7. PubMed ID: 5639734 [No Abstract] [Full Text] [Related]
44. AMA drug evaluations. A praiseworthy venture. Robinson RR; Clapp JR Arch Intern Med; 1971 Jul; 128(1):147-8. PubMed ID: 5088410 [No Abstract] [Full Text] [Related]
45. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of the American Stroke Association. Saver JL; Acad Emerg Med; 2007 Apr; 14(4):e57-8. PubMed ID: 17322569 [No Abstract] [Full Text] [Related]
46. Medication errors caused by confusion of drug names. Hoffman JM; Proulx SM Drug Saf; 2003; 26(7):445-52. PubMed ID: 12735783 [TBL] [Abstract][Full Text] [Related]
47. Patents and the US FDA's definition of 'cocrystal': an ordinary and customary meaning? Lindeman JA Pharm Pat Anal; 2012 Nov; 1(5):513-5. PubMed ID: 24236917 [No Abstract] [Full Text] [Related]
48. Is the bioanalytical community ready to revise the use of certain validation concepts and nomenclature? Olsson AO; Liljeblad M; Nilsson LB; Silvester S Bioanalysis; 2012 Jul; 4(14):1705-8. PubMed ID: 22877214 [No Abstract] [Full Text] [Related]
49. Guidelines on gifts to physicians from industry: an update. American Medical Association. Council on Ethical and Judicial Affairs Food Drug Law J; 1992; 47(4):445-58. PubMed ID: 11654909 [No Abstract] [Full Text] [Related]
50. [Letters from Washington. Food and Drug Administration and medical technology: at an impasse?]. Gelijns AC Ned Tijdschr Geneeskd; 1993 Jan; 137(3):146-50. PubMed ID: 8423866 [No Abstract] [Full Text] [Related]
51. The American College of Allergists and the Food and Drug Administration. Boggs PB Ann Allergy; 1986 Jun; 56(6):443. PubMed ID: 3717709 [No Abstract] [Full Text] [Related]
52. "Suit..the word to the action". JAMA; 1967 Jun; 200(11):984. PubMed ID: 6071644 [No Abstract] [Full Text] [Related]
53. Are drug proprietary names necessary? D'Arcy PF; Hadden DR Adverse Drug React Toxicol Rev; 2000 Jun; 19(2):117-21. PubMed ID: 10967746 [No Abstract] [Full Text] [Related]
54. Veterinary drug availability. Gloyd J J Am Vet Med Assoc; 1980 Apr; 176(7):611-4. PubMed ID: 7372533 [No Abstract] [Full Text] [Related]
55. The evolution of new drug legislation. Kelsey FO BMQ; 1966 Sep; 17(3):72-81. PubMed ID: 5978212 [No Abstract] [Full Text] [Related]
56. ADA joins national coding and provider classification projects. J Am Diet Assoc; 1999 Jan; 99(1):18. PubMed ID: 9917725 [No Abstract] [Full Text] [Related]
57. A backward step in drug control. Feldman EG J Pharm Sci; 1966 Sep; 55(9):i. PubMed ID: 5918545 [No Abstract] [Full Text] [Related]
58. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970. Tobbell DA Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387 [TBL] [Abstract][Full Text] [Related]
59. Preparation and use of drug master files in the pharmaceutical industry. Personeus GR; Ascione P J Parenter Sci Technol; 1981; 35(2):63-9. PubMed ID: 7229835 [No Abstract] [Full Text] [Related]
60. Pharmaceutical analysis: key to drug quality and control. Florey KG; Brewer GA Am Pharm; 1981 Aug; NS21(8):30-5. PubMed ID: 7270421 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]